Merck’s drug sotatercept approved by FDA for treatment of rare and fatal lung condition
Merck’s Winrevair Drug Approval Signals Hope for Patients with Rare Lung Condition The Food and Drug Administration recently approved a groundbreaking new drug from Merck designed to treat pulmonary arterial hypertension (PAH), a progressive and … Read more